BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2415641)

  • 1. Expression of HLA-DR by anagen hair follicles in alopecia areata.
    Messenger AG; Bleehen SS
    J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy.
    Bröcker EB; Echternacht-Happle K; Hamm H; Happle R
    J Invest Dermatol; 1987 May; 88(5):564-8. PubMed ID: 3471816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration.
    Khoury EL; Price VH; Greenspan JS
    J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
    van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J
    Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata.
    Zhang JG; Oliver RF
    Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA-DR in hair follicles in alopecia areata.
    Messenger AG; Bleehen SS; Slater DN; Rooney N
    Lancet; 1984 Aug; 2(8397):287-8. PubMed ID: 6146835
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of T6 antigen on keratinocytes in alopecia areata.
    Lotti T; Knoepfel B; Zangheri M; Panconesi E
    Int J Dermatol; 1992 Feb; 31(2):103-6. PubMed ID: 1559731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines.
    Mcdonagh AJ; Snowden JA; Stierle C; Elliott K; Messenger AG
    Br J Dermatol; 1993 Sep; 129(3):250-6. PubMed ID: 7506926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata.
    Hamm H; Klemmer S; Kreuzer I; Steijlen PM; Happle R; Bröcker EB
    Arch Dermatol Res; 1988; 280(3):179-81. PubMed ID: 3377529
    [No Abstract]   [Full Text] [Related]  

  • 11. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
    Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
    J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Takeuchi S; Sato Y
    Acta Derm Venereol; 1980; 60(1):33-7. PubMed ID: 6153831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural abnormalities in the dermal papillae of both lesional and clinically normal follicles from alopecia areata scalps.
    Nutbrown M; MacDonald Hull SP; Baker TG; Cunliffe WJ; Randall VA
    Br J Dermatol; 1996 Aug; 135(2):204-10. PubMed ID: 8881661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response.
    Tobin DJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):176-81. PubMed ID: 14582669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
    Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
    Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.